- Investing Ideas
- /
- Top Rated Asian Stocks
Top Rated Asian Stocks
UPDATED Apr 16, 2024
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
181 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
LTODL | ₹43.70 | -3.5% | 56.1% | ₹4.9t | ₹48.02 | PE39.1x | E23.2% | 0.7% | Capital Goods | ||
0A4M | US$137.35 | -1.6% | 12.2% | US$52.6b | US$150.20 | PE97.2x | E20.2% | n/a | Healthcare | ||
0YP5 | €1,416.51 | -2.5% | -2.6% | €44.4b | €1,641.68 | PE63.6x | E19.8% | n/a | Diversified Financials | ||
ADYENA | €1,444.10 | -1.0% | -0.8% | €44.4b | €1,652.87 | PE64.4x | E19.8% | n/a | Diversified Financials | ||
0LF5 | US$81.70 | -5.1% | 31.8% | US$40.1b | US$93.85 | PE224.3x | E30.9% | n/a | Media | ||
0A7Y | US$145.49 | -1.5% | 47.0% | US$25.7b | US$155.73 | PE31.6x | E21.5% | 0.5% | Capital Goods | ||
0NI1 | €543.20 | 3.4% | 100.7% | €23.6b | €538.96 | PE40.7x | E27.7% | 1.0% | Capital Goods | ||
RHMD | €548.60 | 5.2% | 105.2% | €23.6b | €536.03 | PE41.4x | E27.7% | 1.0% | Capital Goods | ||
KSPIL | US$120.60 | 0% | 63.0% | US$25.0b | US$142.53 | PE13.2x | E17.0% | 5.8% | Diversified Financials | ||
0HBP | kr167.49 | 1.3% | 8.0% | kr269.8b | kr166.29 | PE28.6x | E16.7% | 3.9% | Retail | ||
HMBS | kr164.60 | -0.5% | 6.7% | kr267.0b | kr165.10 | PE28.3x | E16.7% | 3.9% | Retail | ||
KSPI | US$120.60 | 5.4% | 59.9% | US$22.8b | US$130.21 | PE12.2x | E17.0% | 6.3% | Diversified Financials | ||
80TE | US$95.10 | 0% | n/a | US$17.7b | US$112.12 | PE10.3x | E21.6% | 8.0% | Diversified Financials | ||
0HNC | US$91.58 | 2.6% | -7.4% | US$17.2b | US$110.88 | PE102.9x | E30.8% | n/a | Pharmaceuticals & Biotech | ||
0K6R | US$134.35 | -2.7% | 29.4% | US$13.4b | US$154.04 | PE53.6x | E26.7% | n/a | Pharmaceuticals & Biotech | ||
KOGO | kr754.25 | 11.7% | 72.1% | kr133.8b | kr675.55 | PE36x | E13.8% | 1.8% | Capital Goods | ||
0F08 | kr760.20 | 2.9% | 64.3% | kr133.8b | kr680.88 | PE36x | E13.8% | 1.8% | Capital Goods | ||
0J9P | US$53.70 | -2.1% | -26.6% | US$11.9b | US$76.74 | PE20x | E20.1% | n/a | Pharmaceuticals & Biotech | ||
VIFNEZ | CHF172.95 | 4.4% | n/a | CHF11.1b | CHF164.73 | PE75.9x | E28.5% | 1.2% | Pharmaceuticals & Biotech | ||
DIEB | €198.45 | 0% | 15.0% | €10.9b | €236.52 | PE21.9x | E25.2% | 1.8% | Retail | ||
0ON7 | €201.55 | -3.7% | 17.2% | €10.8b | €243.52 | PE21.6x | E25.2% | 1.8% | Retail | ||
KAPL | ₸40.15 | -2.1% | 38.0% | ₸4.7t | ₸46.26 | PE11.7x | E13.7% | 4.1% | Energy | ||
KAP | ₸38.20 | -6.9% | 31.0% | ₸4.7t | ₸45.51 | PE11.3x | E13.7% | 4.2% | Energy | ||
0QXN | €26.93 | 3.8% | -27.3% | €7.0b | €32.37 | PE84.2x | E28.5% | n/a | Retail |